工业X射线探伤防护剂量水平的研究

本文介绍了用实验方法研究不同管电压, 钢板厚度与散射线之间的关系.结果表明, 透射比随管电压升高而增加, 并随钢板厚度增加而下降；散射比随散射角的增大而逐渐下降, 至180°时为最低值。此研究为X射线探伤作业的辐射防护提供了依据。     

微电流与低浓度氯对水中脊髓灰质炎I型病毒的协同灭活效应

目的　观察微电流 (low amperage direct current,LDC)与游离氯 (free chlorine,FC)对水中脊髓灰质炎 I型病毒 (PV1 )的协同灭活效果 .方法　用微电流 0 .4～ 1 .2 m A·cm-2 协同氯 0 .2～ 0 .3 mg· L-1 处理污染 PV1水样 ,比较作用前后灭活率 K值评价灭活效果 ,用 Berenbaum方法判断微电流与氯灭活病毒有无协同效应 ,用蚀斑形成试验 (PFUA)和病毒细胞酶联免疫试验 (VELCIA)检测感染性和抗原性变化 .结果　实验观察到微电流达到 0 .4 m A· cm-2 对水中PV1有弱灭活作用 ,电流密度达到 1 .2 m A· cm-2 与 0 .2mg· L-1氯有协同灭活效应 ,微电流 1 .2 m A· cm-2与氯 0 .3mg· L-1协同消毒 30 min,水中病毒减少 4.0 8个对数级 ,而单独用氯仅减少 1 .93个对数级 ;协同作用后病毒感染性灭活增强 ,而抗原性灭活不明显 .结论　微电流协同氯可提高低浓度氯灭活水中病毒的效果     

彩色多普勒超声诊断糖尿病下肢动脉病变的临床价值

目的 :研究彩色多普勒超声在糖尿病下肢动脉病变诊断中的应用。方法 :对临床上诊断为非胰岛素依赖型糖尿病 (NIDDM)患者发生下肢动脉病变的 6 2例进行彩色多普勒超声检查 ,并以 2 0例无糖尿病正常人作对照。结果 :6 2例NIDDM患者中阳性结果 4 0例 ,发病率 6 4 .5 2 %。正常对照组 2 0例 ,阳性结果 4例 ,发病率2 0 % ,下肢动脉病变程度与NIDDM组有显著性差异P <0 .0 1。结论 :彩色多普勒超声诊断糖尿病下肢动脉病变具有重要临床意义 ,且下肢动脉病变与NIDDM有密切相关性。     

Low sodium haemodialysis reduces interdialytic fluid consumption but paradoxically increases post-dialysis thirst.

BACKGROUND: Interdialytic weight gain (IDWG) can be reduced by lowering the dialysate sodium concentration ([Na]) in haemodialysis patients. It has been assumed that this is because thirst is reduced, although this has been difficult to prove. We compared thirst patterns in stable haemodialysis patients with high and low IDWG using a novel technique and compared the effect of low sodium dialysis (LSD) with normal sodium dialysis (NSD). METHODS: Eight patients with initial high IDWG and seven with low IDWG completed hourly visual analogue ratings of thirst using a modified palmtop computer during the dialysis day and the interdialytic day. The dialysate [Na] was progressively reduced by up to 5 mmol/l over five treatments. Dialysis continued at the lowest attained [Na] for 2 weeks and the measurements were repeated. The dialysate [Na] then returned to baseline and the process was repeated. RESULTS: Baseline interdialytic day mean thirst was higher than the dialysis day mean for the high IDWG group (49.9+/-14.0 vs 36.2+/-16.6) and higher than the low weight gain group (49.9+/-14.0 vs 34.1+/-14.6). This trend persisted on LSD, but there was a pronounced increase in post-dialysis thirst scores for both groups (high IDWG: 46+/-13 vs 30+/-21; low IDWG: 48+/-24 vs 33+/-18). The high IDWG group demonstrated lower IDWG during LSD than NSD (2.23+/-0.98 vs 2.86+/-0.38 kg; P<0.05). CONCLUSIONS: Our results indicate that patients with high IDWG experience more intense feelings of thirst on the interdialytic day. LSD reduces their IDWG, but paradoxically increases thirst in the immediate post-dialysis period.     

父母亲社会经济状况与低出生体质量儿的相关性探讨

①目的 探讨父母亲社会经济状况与低出生体质量儿发生的关系。②方法 采用病例对照研究方法，对190名低出生体质量儿和750名正常出生体质量儿的父母亲进行了相关因素调查，用Logistic回归分析进行了危险因素分析。③结果 母亲年龄大于35岁、母亲的职业为教师或农民、父亲吸烟、母亲孕期吸烟及年家庭收人低是发生低出生体质量儿的危险因素(OR=1．280～7．290)，母亲身高与低出生体质量儿的发生率呈负相关关系(OR=0．898)。④结论 父母亲的社会经济状况与低出生体质量儿的发生有关。     

两种剂量奥曲肽治疗食管及胃曲张静脉出血效果比较

①目的　比较两种剂量奥曲肽治疗食管、胃曲张静脉出血的临床效果。②方法　将 88例食管、胃曲张静脉出血病人随机分为奥曲肽 5 0 μg/h和 2 5 μg/h剂量组 ,观察平均止血时间、止血率、再出血率和不良反应。 ③结果　 5 0 μg/h组平均止血时间明显短于 2 5 μg/h组 (t=2 .2 4 ,P <0 .0 5 ) ,总止血率明显高于 2 5 μg/h组 (χ2 =5 .36 0 ,P <0 .0 5 ) ,再出血率较 2 5 μg/h组低 (χ2 =7.990 ,P <0 .0 5 )。两组均有 1例病人出现恶心。④结论　奥曲肽 5 0 μg/h剂量治疗食管、胃曲张静脉出血的效果优于 2 5 μg/h剂量     

橡胶木粉填充LLDPE复合材料的结构和力学性能

用橡胶木粉填充线性低密度聚乙烯(LLDPE)，研究了酸、碱溶液预处理木粉的效果和硅烷偶联荆(KH-570)、MMA接枝的天然橡胶胶乳(MGL-30)两种改性剂对橡胶木粉表面改性的效果，以及未粉粒径和填充量等对木粉／LLDPE复合材料力学性能的影响，并用SEM对复合材料拉伸断面的形态结构进行了分析。结果表明：木粉的拉径、木粉填充量和改性荆用量对复合材料的力学性能有较大的影响，经碱溶液预处理再用改性荆改性后的木粉能有效地改善木粉与LLDPE的界面粘结强度，提高橡胶木粉／LLDPE复合材料的力学性能。     

Study on Bone Mineral Density and its Influencing Factors among 1 214 Older Adults in Xuhui District, Shanghai

Osteoporosis is a common disease in older adults. The basic evidence for the diagnosisof osteoporosis is the decrease of bone mineral density (BMD) [1]. Studies showed that the risk of fractures would rise as the bone mineral density decreased, and the me…     

The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: Pharmacodynamic implications

The apparent concentration-effect relationship is the ensemble of many effector units (such as individual cells or channels) that do not always exhibit a uniform stimulus-effect relationship. This concept is substantiated by many observations of heterogeneity in receptor-effector populations including hormone secreting cells, response to hormonal stimuli, activity pattern of second messengers, stimulus-evoked synaptic currents, and single ion channels. The relationship between drug concentration and magnitude of pharmacologic response is commonly described by the sigmoidalE _max model which was derived from the Hill equation. The sigmoidicity factor (N) in this model is assumed to be a pure mathematical parameter without physiological connotations. This work demonstrates that the numerical value ofN (measured empirically) is the product of two factors: (i) the degree of heterogeneity of the effector subunits, i.e., the elemental component that upon drug stimulus contributes its pharmacological effect independently and does not interact with other subunits (it could range from a single receptor up to a whole tissue), and (ii) value ofN ^*—the shape factor of the subunits' concentration-effect relationship. A special case of this approach occurs whenN ^*>5, which is an on-off case. HereN is determined by the distribution (density equation) of the subunit values. In case of heterogeneity of the microparameters of the effector subunits the apparentN will always have a lower value thanN ^*. According to this theory it can be concluded that without knowledge of the distribution of the microparameters no mechanistic interpretation can be deduced from the apparentN value. If in the futureN ^* can be determined by theoretical or experimental methods, the distribution function relatingN ^* toN can be calculated. The relevance of this theory is increased in view of the progress being made in advanced research techniques which may enable us to determine the concentration-effect relationship at the level of the individual effector unit.